Developing a Core Outcome Set for Assessing Clinical Safety Outcomes of Prostate Cancer in Clinical Trials of Traditional Chinese Medicine: Protocol for a Mixed Methods Study

BACKGROUND: Among the common malignant tumors in men worldwide, the incidence of prostate cancer ranks second to lung cancer. This disease will bring an economic burden to patients and their families and can reduce the quality of life of patients. Researchers have conducted numerous clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Huichuan, Zhang, Yao, Ren, Jiajun, Wang, Chaoran, Mou, Ruiyu, Li, Xiaojiang, Jia, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442731/
https://www.ncbi.nlm.nih.gov/pubmed/37549007
http://dx.doi.org/10.2196/46794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442731/
https://www.ncbi.nlm.nih.gov/pubmed/37549007
http://dx.doi.org/10.2196/46794

Ejemplares similares